Brief: Edgewise Therapeutics Q3 Basic EPS USD -0.36
07/11/2024 13:00
Nov 07 (Reuters) - Edgewise Therapeutics Q3 operating expenses USD 40.432 million. * Q3 net income USD -34.129 million * Q3 operating income USD -40.432 million
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending